Cytosorbents Corp (NASDAQ:CTSO) showed up in the 13F filings of 50 institutional investors as of March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| AVENIR CORP | 31 Mar, 2026 | 5,215,776 | -14,323 | -0.27% | $2,953,694.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,879,989 | 1,879,989 | 0.00% | $1,064,074.00 |
| Skylands Capital, LLC | 31 Mar, 2026 | 1,707,498 | -147,017 | -7.93% | $966,956.00 |
| Neuberger Berman Group LLC | 31 Mar, 2026 | 1,683,007 | 57,367 | 3.53% | $950,776.00 |
| CM Management, LLC | 31 Mar, 2026 | 1,476,500 | 0 | 0.00% | $836,142.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 782,992 | 12,441 | 1.61% | $443,408.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 707,262 | 103,495 | 17.14% | $400,621.00 |
| Sargent Investment Group, LLC | 31 Mar, 2026 | 549,900 | -62,100 | -10.15% | $311,408.00 |
| Pathstone Holdings, LLC | 31 Mar, 2026 | 499,955 | 0 | 0.00% | $283,124.00 |
| VANGUARD FIDUCIARY TRUST CO | 31 Mar, 2026 | 313,856 | 313,856 | 0.00% | $177,642.00 |
| CIBC Bancorp USA Inc. | 31 Mar, 2026 | 172,649 | 172,649 | 0.00% | $97,771.00 |
| State Street Corp | 31 Mar, 2026 | 159,293 | 0 | 0.00% | $90,208.00 |
| OSAIC HOLDINGS, INC. | 31 Mar, 2026 | 130,419 | 0 | 0.00% | $74,245.00 |
| UBS Group AG | 31 Mar, 2026 | 115,200 | -72 | -0.06% | $65,203.00 |
| Raymond James Financial Inc | 31 Mar, 2026 | 107,751 | -951 | -0.87% | $61,020.00 |
| NWF Advisory Services Inc. | 31 Mar, 2026 | 104,139 | 0 | 0.00% | $58,974.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 100,720 | 600 | 0.60% | $57,038.00 |
| Morgan Stanley | 31 Mar, 2026 | 100,169 | -16,311 | -14.00% | $56,726.00 |
| Northern Trust Corp | 31 Mar, 2026 | 92,540 | 0 | 0.00% | $52,406.00 |
| Key Client Fiduciary Advisors, LLC | 31 Mar, 2026 | 78,457 | 0 | 0.00% | $44,430.00 |